Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Open accessThe DOI matches its Crossref record; 241 of the 245 references it cites were found in a registry or an index.
Abstract
In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to mesenchymal transition (EMT). The cytoskeleton is an active network of three intracellular filaments: actin cytoskeleton, microtubules, and intermediate filaments. These filaments play a central role in the structural design and cell behavior and are necessary for EMT. During EMT, epithelial cells undergo a cellular transformation as manifested by cell elongation, migration, and invasion, coordinated by actin cytoskeleton reorganization. The actin cytoskeleton is an extremely dynamic structure, controlled by a balance of assembly and disassembly of actin filaments. Actin-binding proteins regulate the process of actin polymerization and depolymerization. Microtubule reorganization also plays an important role in cell migration and polarization. Intermediate filaments are rearranged, switching to a vimentin-rich network, and this protein is used as a marker for a mesenchymal cell. Hence, targeting EMT by regulating the activities of their key components may be a potential solution to metastasis. This review summarizes the research done on the physiological functions of the cytoskeleton, its role in the EMT process, and its effect on multidrug-resistant (MDR) cancer cells-highlight some future perspectives in cancer therapy by targeting cytoskeleton.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A schematic diagram illustrating the resistance mechanisms associated with anti-microtubule drugs. These drugs cross the lipid bilayer of the cell membrane and then bind themselves to β-tubulin to alter the microtubule dynamics, causing mitotic arrest and consequent apoptosis. Drugs can be effluxed before reaching the cellular target with the aid of functional drug transport protein. Disruption in the tubulin/microtubule system can avert anti-microtubule drugs from disrupting the microtubules and leading to drug resistance. Before drug binding occurs, signaling and anti-apoptotic factors may also contribute to drug resistance. MF: microfilaments, Mt: microtubules. [212]. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.](https://figures.cochat.ai/paper-figures/c0e6c310a36f4170b5ceec5f7c0b9936/cytoskeletal-dynamics-in-epithelial-mesenchymal-transition-insights-into-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A critical step in the progression of ovarian cancer metastasis is the epithelial-to-mesenchymal transition (EMT), which is characterized by the loss of E-cadherin, cytoskeletal remodeling and changes in proliferation, motility and apoptosis (Ahmed et al., 2007; Moreno-Bueno et al., 2009; Datta et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Datta et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–241 of 241
Shin, S. Y., Kim, J., Yoon, H. S., Choi, Y., Koh, D., Lim, Y., & Lee, Y. H. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4034688 · Cited by 47
Organization of Non-centrosomal Microtubules in Epithelial Cells
Toya, M., & Takeichi, M. (2016) · Cell Structure and Function · doi:10.1247/csf.16015 · Cited by 47
Loss of CAMSAP3 promotes EMT via the modification of microtubule–Akt machinery
Pongrakhananon, V., Wattanathamsan, O., Takeichi, M., Chetprayoon, P., & Chanvorachote, P. (2018) · Journal of Cell Science · doi:10.1242/jcs.216168 · Cited by 46
Eitaki, M., Yamamori, T., Meike, S., Yasui, H., & Inanami, O. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-469 · Cited by 45 · cited 6×
“One evidence comes from a gastric adenocarcinoma study that microtubule alternation promotes cell motility via Rho GTPase [67].”
BackgroundInfluentialARPC2 promotes breast cancer proliferation and metastasis
Cheng, Z., Wei, W., Wu, Z., Wang, J., Ding, X., Sheng, Y., Han, Y., & Wu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7113 · Cited by 45
Hoy, S. M. (2014) · Drugs · doi:10.1007/s40265-014-0291-8 · Cited by 44
Tropomyosin isoforms define distinct microfilament populations with different drug susceptibility
Creed, S. J., Bryce, N. S., Naumanen, P., Weinberger, R. P., Lappalainen, P., Stehn, J. R., & Gunning, P. W. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.03.004 · Cited by 44
Chen, L., Yuan, Y., Kar, S., Kanchi, M. M., Arora, S., Kim, J. E., Koh, P. F., Yousef, E. M., Samy, R. P., Shanmugam, M. K., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0739 · Cited by 44
Self-citationSanders, A. J., Ye, L., Mason, M. D., & Jiang, W. G. (2010) · Angiogenesis · doi:10.1007/s10456-010-9188-7 · Cited by 38
The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity
Schweikart, K. M., Guo, L., Shuler, Z., Abrams, R. M. C., Chiao, E. T., Kolaja, K. L., & Davis, M. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.12.005 · Cited by 37
Structural basis of EB1 effects on microtubule dynamics
Coquelle, F. M., Vitre, B., & Arnal, I. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370997 · Cited by 36
Fascin-1 as a biomarker and prospective therapeutic target in colorectal cancer
Adams, J. C. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.976557 · Cited by 34 · cited 1×
“Another actin-binding protein fascin is upregulated during migration by stimulating the formation of invadopodia and filopodia [96].”
BackgroundProteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response
He, J., Whelan, S. A., Lu, M., Shen, D., Chung, D. U., Saxton, R. E., Faull, K. F., Whitelegge, J. P., & Chang, H. R. (2011) · International Journal of Proteomics · doi:10.1155/2011/896476 · Cited by 34
Endo, Y., Takeda, K., Mohan, N., Shen, Y., Jiang, J., Rotstein, D. S., & Wu, W. J. (2018) · Oncotarget · doi:10.18632/oncotarget.26461 · Cited by 34
Formin-based control of the actin cytoskeleton during cytokinesis
Bohnert, K. A., Willet, A. H., Kovar, D. R., & Gould, K. L. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130208 · Cited by 33 · cited 2×
“Actin organization is vital for different cellular processes like cell motility, organelle movement, maintenance of cell junctions, and cell shape [71,72].”
BackgroundMethod[The role of matrixmetalloproteinases in the tumor growth and metastasis].
Velinov, N., Poptodorov, G., Gabrovski, N., & Gabrovski, S. (2010) · PubMed · Cited by 33
Hirooka, S., Akashi, T., Ando, N., Suzuki, Y., Ishida, N., Kurata, M., Takizawa, T., Kayamori, K., Sakamoto, K., Fujiwara, N., et al. (2011) · Pathobiology · doi:10.1159/000322734 · Cited by 32
Duncan, M. D., Harmon, J. W., & Duncan, K. L. K. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0276 · Cited by 31
EPLIN is a Negative Regulator of Prostate Cancer Growth and Invasion
Sanders, A. J., Martin, T. A., Ye, L., Mason, M. D., & Jiang, W. G. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.03.038 · Cited by 31
Gamma-actin is involved in regulating centrosome function and mitotic progression in cancer cells
Po’uha, S. T., & Kavallaris, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1120920 · Cited by 30
de Vicente, J. C., Rosado, P., Lequerica–Fernández, P., Allonca, E., de Villalaín, L., & Hernández, G. (2012) · Head & Neck · doi:10.1002/hed.23038 · Cited by 29 · cited 1×
“FAK is a tyrosine kinase, and it has a role in actin remodeling dynamics during cell adhesion, and motility and its expression and activity correlate with increased metastatic phenotype [83].”
BackgroundCalaghan, S. C., White, E., Bedut, S., & Guennec, J. L. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00405.x · Cited by 27
Gagat, M., Grzanka, D., Izdebska, M., & Grzanka, A. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1357 · Cited by 27 · cited 1×
“F-actin filaments are stabilized by amplifying β-catenin and the ZO-1 proteins in the cells that overexpress tropomyosin1 [74].”
BackgroundCortactin in Epithelial–Mesenchymal Transition
Ji, R., Zhu, X., Wang, Z., & Huang, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.585619 · Cited by 27
Meany, H. J., Sackett, D. L., Maris, J. M., Ward, Y., Krivoshik, A., Cohn, S. L., Steinberg, S. M., Balis, F. M., & Fox, E. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22267 · Cited by 26
Pedersini, R., Vassalli, L., Claps, M., Tulla, A., Rodella, F., Grisanti, S., Amoroso, V., Roca, E., Simoncini, E., & Berruti, A. (2018) · Oncology · doi:10.1159/000489063 · Cited by 26
Lim, M. M. K., Wee, J. W. K., Soong, J. C., Chua, D., Tan, W., Lizwan, M., Li, Y., Teo, Z. Q., Goh, W. W. B., Zhu, P., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0904-z · Cited by 26
Traub, P., Kühn, S., & Grüb, S. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1205 · Cited by 25
Pizzuti, L., Krasniqi, E., Barchiesi, G., Mazzotta, M., Barba, M., Amodio, A., Massimiani, G., Pelle, F., Kayal, R., Vizza, E., et al. (2019) · Journal of Cancer · doi:10.7150/jca.35109 · Cited by 25
Jiang, G.-B., Fang, H.-Y., Dy, T., Xp, C., & Fl, C. (2019) · PubMed · doi:10.26355/eurrev_201905_17811 · Cited by 25
Potential Role of Thymosin Beta 4 in Liver Fibrosis
Kim, J., & Jung, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160510624 · Cited by 22
So, S., Lee, Y., Park, J., Lee, J.-Y., Kim, D., Hwang, J., Shin, J., Kim, C., Han, Y., Kang, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233057 · Cited by 22
Monisha, J., Roy, N. K., Padmavathi, G., et al. (2018) · Preprints.org · doi:10.20944/preprints201805.0076.v1 · Cited by 22
Involvement of the SATB1/F-actin complex in chromatin reorganization during active cell death
Grzanka, D., Gagat, M., & Izdebska, M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1710 · Cited by 20 · cited 1×
“Actin organization is vital for different cellular processes like cell motility, organelle movement, maintenance of cell junctions, and cell shape [71,72].”
BackgroundHagio, M., Matsuda, Y., Suzuki, T., & Ishiwata, T. (2012) · Molecular and Clinical Oncology · doi:10.3892/mco.2012.1 · Cited by 19
Leirdal, M., Shadidi, M., Røsok, Ø., & Sioud, M. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.2.217 · Cited by 19 · cited 1×
“WASH protein is overexpressed in a breast cancer cell line SKBr3 and may be a potential biomarker for EMT [93].”
BackgroundLandowski, T. H., Samulitis, B. K., & Dorr, R. T. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0019-8 · Cited by 17
Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients
Fang, C., Li, J., Deng, T., Li, B., Geng, P., & Zeng, X. (2019) · Medical Science Monitor · doi:10.12659/msm.912404 · Cited by 16
Zankov, D. P., & Ogita, H. (2015) · BioMed Research International · doi:10.1155/2015/314178 · Cited by 13
Hao, R., Liu, Y., Du, Q., Liu, L., Chen, S., You, H., & Dong, Y. (2019) · Breast Cancer · doi:10.1007/s12282-019-00981-4 · Cited by 12
BPR0C305, an orally active microtubule-disrupting anticancer agent
Li, W.-T., Yeh, T., Song, J., Yang, Y., Chen, T.-W., Lin, C.-H., Chen, C.-P., Shen, C.-C., Hsieh, C.-C., Lin, H., et al. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000014 · Cited by 9
Cited by
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Self-citationSTAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., fathi, N., Rezaei, S., Hejazi, E. S., Kakavand, A., Saebfar, H., Hashemi, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106311 · Cited by 185
Paskeh, M. D. A., Ghadyani, F., Hashemi, M., Abbaspour, A., Zabolian, A., Javanshir, S., Razzazan, M., Mirzaei, S., Entezari, M., Goharrizi, M. A. S. B., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106553 · Cited by 177
Self-citationHashemi, M., Arani, H. Z., Orouei, S., Fallah, S., Ghorbani, A., Khaledabadi, M., Kakavand, A., Tavakolpournegari, A., Saebfar, H., Heidari, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113774 · Cited by 166
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
Deng, S., Leong, H. C., Datta, A., Gopal, V., Kumar, A. P., & Yap, C. T. (2022) · Cancers · doi:10.3390/cancers14071652 · Cited by 135
“During the EMT process, the cytoskeleton is restructured under a coordinated regulation of ABPs, MTBPs, and regulators of IFs, to weaken cell-cell attachment and strengthen cell-matrix adhesions that transform cancer cells from the stationary epithelial type into migratory mesenchymal type [47,48].”
BackgroundSelf-citation
Metadata
- Authors
- Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., Kumar, A. P., & Yap, C. T.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Kumar, Alan Prem
- Yap, Celestial T.
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-04-14
- Volume
- 13
- Issue
- 8
- Pages
- 1882
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8070945
- OpenAlex
- W3156599094
- Cited by
- 184
- References
- 245
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 34 · 2023: 33 · 2022: 30 · 2021: 12
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Medical Research Council (r-185-000-353-213)
- Ministry of Education - Singapore (MOE-T2EP30120-0016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- epithelial-mesenchymal transition, cytoskeleton, actin cytoskeleton, microtubules, intermediate filaments, vimentin, metastasis, cell migration, cell invasion, actin-binding proteins, multidrug resistance, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.